Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$110M |
| 2 |
Willis Towers Watson
WTW
|
+$70.4M |
| 3 |
Gen Digital
GEN
|
+$63.3M |
| 4 |
Goldman Sachs
GS
|
+$53.6M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$51.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$110M |
| 2 |
Meta Platforms (Facebook)
META
|
+$72.2M |
| 3 |
Global Payments
GPN
|
+$43.3M |
| 4 |
Cardinal Health
CAH
|
+$41.2M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$40.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.08% |
| 2 | Technology | 14.83% |
| 3 | Healthcare | 8.61% |
| 4 | Consumer Discretionary | 7.67% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOGL
1676
DELISTED
Golden Ocean Group
GOGL
| $240K | ﹤0.01% |
22,300
-9,400
| -30% | -$98K |
|
|
WBK
1677
DELISTED
Westpac Banking Corporation
WBK
| $239K | ﹤0.01% |
+12,900
| New | +$241K |
|
1678
EPR Properties
EPR
$4.64B
| $237K | ﹤0.01% |
4,800
-5,300
| -52% | -$269K |
|
1679
Quaker Houghton
KWR
$2.79B
| $237K | ﹤0.01% |
1,000
| – | – |
|
1680
Graham Holdings Company
GHC
$4.98B
| $236K | ﹤0.01% |
400
| – | – |
|
|
VBTX
1681
DELISTED
Veritex Holdings
VBTX
| $236K | ﹤0.01% |
6,000
-900
| -13% | -$31.3K |
|
1682
Valley National Bancorp
VLY
$7.79B
| $236K | ﹤0.01% |
+17,700
| New | +$229K |
|
1683
Travere Therapeutics
TVTX
$6.15B
| $235K | ﹤0.01% |
9,700
-12,260
| -56% | -$225K |
|
1684
Ichor Holdings
ICHR
$2.13B
| $234K | ﹤0.01% |
5,700
+300
| +6% | +$13.7K |
|
1685
Ambarella
AMBA
$3.07B
| $233K | ﹤0.01% |
1,500
-2,878
| -66% | -$331K |
|
1686
Shift4
FOUR
$3.79B
| $233K | ﹤0.01% |
3,000
-4,400
| -59% | -$379K |
|
1687
SeaStar Medical
ICU
$14.1M
| $233K | ﹤0.01% |
+93
| New | +$230K |
|
1688
Medpace
MEDP
$17.3B
| $233K | ﹤0.01% |
+1,230
| New | +$224K |
|
1689
Realty Income
O
$59.8B
| $232K | ﹤0.01% |
+3,697
| New | +$250K |
|
|
TGNA
1690
DELISTED
TEGNA Inc
TGNA
| $232K | ﹤0.01% |
+11,800
| New | +$214K |
|
1691
CEL-SCI Corp
CVM
$24.3M
| $231K | ﹤0.01% |
700
-744
| -52% | -$217K |
|
1692
DXC Technology
DXC
$1.7B
| $231K | ﹤0.01% |
+6,870
| New | +$260K |
|
1693
Regencell Bioscience
RGC
$2.62B
| $231K | ﹤0.01% |
+387,600
| New | +$175K |
|
1694
Grupo Aeroportuario Centro Norte
OMAB
$4.97B
| $230K | ﹤0.01% |
+4,900
| New | +$238K |
|
|
KW
1695
DELISTED
Kennedy-Wilson Holdings
KW
| $228K | ﹤0.01% |
10,900
+100
| +0.9% | +$2.08K |
|
1696
Littelfuse
LFUS
$10.2B
| $228K | ﹤0.01% |
836
-44
| -5% | -$11.7K |
|
1697
Utz Brands
UTZ
$1.26B
| $228K | ﹤0.01% |
13,300
-3,200
| -19% | -$65K |
|
1698
Goldman Sachs BDC
GSBD
$1.13B
| $227K | ﹤0.01% |
12,400
-4,300
| -26% | -$82.2K |
|
|
IAA
1699
DELISTED
IAA, Inc. Common Stock
IAA
| $227K | ﹤0.01% |
4,157
-111,443
| -96% | -$6.18M |
|
1700
Community Bank
CBU
$3.32B
| $226K | ﹤0.01% |
3,300
+600
| +22% | +$43K |
|
Similar funds
Steve Schonfeld's Q3 2021 Portfolio in Review
As of Q3 2021, Steve Schonfeld held 2,698 positions worth $9.68B, up 3% from $9.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Steve Schonfeld deployed $368M of net new capital in Q3 2021, opening 807 new positions and adding to 606 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $110M trimmed.
- Steve Schonfeld's largest Q3 2021 buy was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
- Steve Schonfeld added most to Willis Towers Watson in Q3 2021, an estimated $70.4M increase.
- Steve Schonfeld's biggest Q3 2021 reduction was Amazon, cutting an estimated $110M.
- Steve Schonfeld fully exited Cardinal Health in Q3 2021, selling an estimated $41.2M.
- Steve Schonfeld's ten largest holdings make up 11% of its $9.68B portfolio in Q3 2021.
- Steve Schonfeld opened 807 new positions and closed 588 in Q3 2021.
- Steve Schonfeld's portfolio value rose 3% quarter-over-quarter to $9.68B.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.